-
1 Comment
Beijing Tong Ren Tang Chinese Medicine Company Limited is currently in a long term uptrend where the price is trading 24.0% above its 200 day moving average.
From a valuation standpoint, the stock is 99.5% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.9.
Beijing Tong Ren Tang Chinese Medicine Company Limited's total revenue sank by 0.0% to $305M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $99M since the same quarter in the previous year.
Finally, its free cash flow fell by 79.3% to $27M since the same quarter in the previous year.
Based on the above factors, Beijing Tong Ren Tang Chinese Medicine Company Limited gets an overall score of 2/5.
Sector | Healthcare |
---|---|
Industry | Drug Manufacturers - Specialty & Generic |
ISIN | HK0000145638 |
Exchange | F |
CurrencyCode | EUR |
Target Price | None |
---|---|
Dividend Yield | 4.3% |
Market Cap | 815M |
PE Ratio | 13.79 |
Beta | 0.43 |
Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates retail outlets in Hong Kong and in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. Beijing Tong Ren Tang Chinese Medicine Company Limited was founded in 1669 and is based in Wan Chai, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for TQR.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025